Effects of p38 MAP kinase inhibitors on the differentiation and maturation of erythroid progenitors

Toxicologic Pathology
Deidre A DalmasMarshall S Scicchitano

Abstract

In rodents, p38 MAP kinase inhibitors (p38is) induce bone marrow hypocellularity and reduce reticulocyte and erythrocyte counts. To identify target cell populations affected, a differentiating primary liquid erythroid culture system using sca-1(+)cells from mouse bone marrow was developed and challenged with p38is SB-203580, SB-226882, and SB-267030. Drug-related alterations in genes involved at different stages of erythropoiesis, cell-surface antigen expression (CSAE), burst-forming unit erythroid (BFU-E) colony formation, and cellular morphology (CM), growth (CG), and viability were evaluated. CSAE, CM, and decreases in BFU-E formation indicated delayed maturation, while CG and viability were unaffected. Terminal differentiation was delayed until day 14 versus day 7 in controls. CSAE demonstrated higher percentages of sca-1(+)cells after day 2 and reduced percentages of ter119(+) cells after day 7 in all treated cultures. Real-time reverse transcriptase polymerase chain reaction revealed a transient delay in expression of genes involved at early, intermediate, and late stages of erythropoiesis, followed by rebound expression at later time points. Results demonstrate p38is do not irreversibly inhibit erythrogenesis but induce ...Continue Reading

References

Nov 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·S HeimfeldD Rennick
Jul 1, 1988·Science·G J SpangrudeI L Weissman
Jun 1, 1984·The Journal of Experimental Medicine·J W VisserA M de Leeuw
Jan 1, 1982·Differentiation; Research in Biological Diversity·T D Allen, T M Dexter
May 1, 1995·The Journal of Clinical Investigation·C LabbayeC Peschle
May 12, 1995·The Journal of Biological Chemistry·K S PrasadS J Brandt
Feb 28, 1996·JAMA : the Journal of the American Medical Association·P A NuttingS Holcomb
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·T ChengD T Scadden
Feb 1, 1996·Annals of Medicine·J Bungert, J D Engel
May 20, 1998·Biotherapy·A R Migliaccio, G Migliaccio
Sep 11, 1999·Drug Discovery Today·S S BhagwatA Lewis
Oct 16, 1999·British Journal of Haematology·J M FreyssinierS Fichelson
Jun 23, 2000·European Journal of Haematology·S H PopeG P Rodgers
Jan 9, 2001·Experimental Hematology·P IkonomiC T Noguchi
Jun 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H DolznigE W Müllner
Jan 5, 2002·Progress in Medicinal Chemistry·J L AdamsJ C Lee
Sep 10, 2003·Experimental Hematology·Marshall S ScicchitanoLester W Schwartz
Dec 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Shahab UddinAmittha Wickrema
Feb 16, 2005·Nature Biotechnology·Miles A FabianDavid J Lockhart
Sep 24, 2005·Current Topics in Medicinal Chemistry·David M Goldstein, Tobias Gabriel
Dec 6, 2005·Parasitology International·Diana BugarskiPavle Milenković
Dec 28, 2005·Current Medicinal Chemistry·Matthew R Lee, Celia Dominguez
Oct 1, 2006·Drug Discovery Today. Technologies·Guohong LiuQi-Xiang Li

❮ Previous
Next ❯

Citations

Dec 15, 2010·Analytical Chemistry·Wei XuNancy L Allbritton
Mar 12, 2015·Bioscience Reports·Elena B KostovaRobin van Bruggen
Jul 11, 2018·Stem Cells and Development·Morteza ZarrabiMarzieh Ebrahimi
Jul 10, 2019·Stem Cells International·Kateřina ŠtefkováJiří Pacherník

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Software Mentioned

CellQuest
Primer Express

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.